<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01206543</url>
  </required_header>
  <id_info>
    <org_study_id>Cranio 15</org_study_id>
    <nct_id>NCT01206543</nct_id>
  </id_info>
  <brief_title>1.5T Intraoperative MR Imaging in Craniopharyngiomas</brief_title>
  <official_title>Intraoperative Use of a MR Tomography System Combined With Neuronavigation - Analysis of the Craniopharyngioma Subgroup (&quot;Intraoperative Nutzung Eines Kernspintomographie-Systems in Direkter Kopplung Mit Einem Neuronavigations-System&quot;)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hofmann, Bernd, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hofmann, Bernd, M.D.</source>
  <brief_summary>
    <textblock>
      Purpose of this study is to investigate whether intraoperative imaging using a 1.5T MRI in
      craniopharyngioma surgery is useful in order to increase the rate of complete tumor removal.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2002</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <primary_completion_date type="Actual">September 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of additional tumor removal</measure>
    <time_frame>up to 3-4 months following surgery</time_frame>
    <description>Number of patients in whom non suspected tumor remants were indicated by intraoperative MRI and remnants could be removed completely thereafter. Results have to be confirmed in 1st follow up imaging.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of achievement of intended extent of removal</measure>
    <time_frame>up to three months following surgery</time_frame>
    <description>It is examined whether the extent of tumor removal defined prior to surgery was achieved</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnostic reliability</measure>
    <time_frame>within 3 -4 months following surgery</time_frame>
    <description>false positive or negative interpretation of intraoperative imaging determined after follow-up imaging 3 - 4 months following surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complication</measure>
    <time_frame>within 1st week following surgery</time_frame>
    <description>Rate of new deficits following surgery (excluding new endocrine deficits)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Craniopharyngioma</condition>
  <arm_group>
    <arm_group_label>Intraoperative imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intraoperative imaging using 1.5T MRI</intervention_name>
    <description>Intraoperative imaging and determination of degree of resection / complete tumor removal</description>
    <arm_group_label>Intraoperative imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  complex craniopharyngioma &gt; 1cm extension within 2 or more cranial fossae or
             ventricular system

          -  Patient or legal representative able to provide written informed consent

        Exclusion Criteria:

          -  tumor size&lt; 1 cm

          -  Patients with any condition considered a contraindication to MRI

          -  Patients with any condition considered a contraindication for surgery

          -  Hypothalamic disturbances

          -  Hypothalamic edema
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Bernd Hofmann, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurosurgery University of Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2010</study_first_submitted>
  <study_first_submitted_qc>September 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2010</study_first_posted>
  <last_update_submitted>September 21, 2010</last_update_submitted>
  <last_update_submitted_qc>September 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Department of Neurosurgery</name_title>
    <organization>University of Erlangen-Nuremberg</organization>
  </responsible_party>
  <keyword>Craniopharyngioma</keyword>
  <keyword>Surgery</keyword>
  <keyword>Intraoperative imaging</keyword>
  <keyword>Rate of total removal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Craniopharyngioma</mesh_term>
    <mesh_term>Adamantinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

